Aditxt signs definitive deal valuing Ignite Proteomics at USD 150 million

Aditxt, Inc.

Aditxt, Inc.

ADTX

0.00
  • ADiTx’s Ignite Proteomics signed a definitive business combination agreement valuing Ignite at an implied equity value of about USD 150 million.
  • On closing, Ignite is expected to separate from ADiTx and become a standalone public company under a new holding company, Ignite Proteomics, Inc.
  • Ignite equity holders are set to receive newly issued shares based on a USD 10 reference price.
  • The new holding company’s common stock and public warrants are expected to list on the NYSE, subject to customary closing conditions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ADiTx Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260608697723) on June 09, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.